1261398-62-2
1261398-62-2
Chemical Structure
Nilotinib-13C,d3
Synonym(s): AMN107-13C,d3
- CAS No.: 1261398-62-2
- Formula:C2713CH19D3F3N7O
- Molecular Weight:533.53
InChIKey: HHZIURLSWUIHRB-JVXUGDAPSA-N
SMILES: FC(F)(C1=CC(NC(C2=CC(NC3=NC=CC(C4=CN=CC=C4)=N3)=C(C=C2)C)=O)=CC(N5C=NC([13C]([2H])([2H])[2H])=C5)=C1)F
Biological Activity: Nilotinib-13C,d3 is a deuterated labeled Nilotinib[1]. Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Nilotinib-13C,d3 | Nilotinib-13C,d3 is a deuterated labeled Nilotinib. Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nilotinib (Standard) | 99.97% | Nilotinib (Standard) is the analytical standard of Nilotinib. This product is intended for research and analytical applications. Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nilotinib-d6 | 99.87% | Nilotinib-d6 is a deuterium labeled Nilotinib. Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nilotinib-d3 | Nilotinib-d3 is the deuterium labeled Nilotinib. Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nilotinib | 99.94% | Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
